Skip to content

Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02948140
Acronym
IRMA2
Enrollment
27
Registered
2016-10-28
Start date
2016-06-13
Completion date
2020-12-31
Last updated
2021-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Subdiaphragmatic infarction

Brief summary

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal scanner in the detection of subdiaphragmatic infarction associated to the atrial fibrillation in the cerebral infarction.

Interventions

PROCEDUREMRI
PROCEDUREAbdominal scanner

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 * Patient having a CHADS-VAsc Score ≥ 2; * Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR\<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days; * Patient affiliated to a national insurance scheme or beneficiary * Patient having given a written consent

Exclusion criteria

* Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER). * Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip). * Contraindication in injected scanner. * Current pregnancy

Design outcomes

Primary

MeasureTime frame
Number of patients with subdiaphragmatic infarctions detected by abdominal MRI14 days

Secondary

MeasureTime frame
Number of patients with subdiaphragmatic infarctions detected by abdominal scanner14 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026